Expert panel endorses public coverage for abortion pill in Canada
Kelly Grant - HEALTH REPORTER
The Globe and Mail
Published Wednesday, Apr. 19, 2017
A long-awaited expert committee report on the abortion pill is recommending that provincial and territorial governments cover the $300 cost of the medication, The Globe and Mail has learned.
The Common Drug Review (CDR) endorsement is a crucial step toward taxpayer-funded reimbursement for drugs new to Canada, including Mifegymiso, a two-drug combination kit that pro-choice advocates hope will eventually make abortions easier to obtain outside big cities.
Continued at source: Globe & Mail: http://www.theglobeandmail.com/news/national/expert-panel-endorses-public-coverage-for-abortion-pill-in-canada/article34757082/